Value of Whole-body SPECT-CT CzT-based Camera (VERITON-CT) in the Assessment of Chronic Inflammatory Rheumatism With Axial Involvement and Especially of the Sacroiliac Joints
Conditions: Whole-body SPECT-CT CzT-based Sponsors: Central Hospital, Nancy, France Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Assessing Function and Pain After Total Knee Arthroplasty With Combined Femoral and Popliteal Nerve Block
Conditions: Total Knee Arthroplasty; Total Knee Replacement; Total Knee Replacement Surgery; Arthritis Knee; Rehabilitation Interventions: Procedure: Combined Femoral and Popliteal nerve block Sponsors: University of Haifa; Western Galilee Hospital-Nahariya Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Effect of Quadriceps Muscle on Physical Outcome Measures in Women With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Interventions: Other: Ultrasound assessment Sponsors: Afyonkarahisar Health Sciences University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Stopping OsteoARthritis After an ACL Tear
Conditions: Knee Injuries; Anterior Cruciate Ligament Rupture; Osteoarthritis, Knee Interventions: Behavioral: Stop OsteoARthritis (SOAR) program; Behavioral: Living Well after ACLR program Sponsors: University of British Columbia; Arthritis Research Centre of Canada; The Arthritis Society, Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Efficiency of Supervised Exercise Program Versus Mobile-Based Exercise Program in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis Interventions: Other: Pedi@ctivity Exercise Mobile Application Exercise Program; Other: Supervised Exercise Group Sponsors: Istanbul University - Cerrahpasa (IUC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Steps Towards Osteoarthritis Prevention
Conditions: Anterior Cruciate Ligament Injuries Interventions: Behavioral: Adaptive Daily Step Promotion Sponsors: University of Georgia; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Radiographic Migration Analysis of the ATTUNE Cementless CR Fixed-Bearing Total Knee Replacement
Conditions: Osteo Arthritis Knee Interventions: Device: Attune Cementless Sponsors: Canadian Radiostereometric Analysis Network Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis
Conditions: Psoriasis Vulgaris; Psoriatic Arthritis Interventions: Drug: si-544; Drug: Placebo Sponsors: selectION Therapeutics GmbH; FGK Clinical Research GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
Conditions: Systemic Sclerosis Associated Interstitial Lung Disease; Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD); Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Interventions: Drug: GenSci048; Drug: GenSci048 placebo Sponsors: Changchun GeneScience Pharmaceutical Co., Ltd.; West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis
Conditions: Polyarthritis; Rheumatoid Interventions: Other: Patients with planned biotherapy Sponsors: CEN Biotech; MYEXPRESION Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
Mind Your Pain: Validating a Mindful Interoceptive Exposure Task for Patients With Chronic Low Back Pain
Conditions: Chronic Low-back Pain Interventions: Behavioral: MyP Sponsors: University of California, San Francisco; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Rheumatoid Arthritis-associated Interstitial Lung Disease Definition
Conditions: Rheumatoid Arthritis-Associated Interstitial Lung Disease Sponsors: Centre Hospitalier Universitaire de Liege; Boehringer Ingelheim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Virtual Self-Management Program for JIA
Conditions: Juvenile Idiopathic Arthritis Interventions: Other: Virtual Self-Management Program (SMP); Other: No Intervention Sponsors: University of Calgary; The Hospital for Sick Children; University of Toronto; University of Alberta; University of Manitoba; University of British Columbia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
A Study of IMB-101 in Healthy Volunteers and Participants With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Interventions: Drug: IMB-101; Drug: Placebo Sponsors: IMBiologics Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
First Rheumatoid Arthritis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001
BOSTON and HANGZHOU and SHANGHAI, China, Dec. 20, 2023. Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as ' Lynk Pharmaceuticals ' ), an innovative clinical stage company, announced that it has dosed the first patient with Rheumatoid Arthritis... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 21, 2023 Category: Pharmaceuticals Source Type: clinical trials
